There are 3 papers on levodopa equivalent daily dose in aging research: 1 trial and 1 observational study in people, 1 review.
3 papers study it15 more mention it1 finding
1 new paper in 30 daysSee all 18 papers on levodopa equivalent daily dose
- Human trial1
- Humans1
Interventions
1Deep brain stimulation
downin humans1
1 study
Deep brain stimulation
downin humans1
Deep brain stimulation is linked with lower levodopa equivalent daily dose in humans (Parkinson's disease) (p < 0.05).
“The levodopa equivalent daily dose (LEDD) was significantly reduced at the 2-year follow-up (p < 0.05).”
HumansParkinson's disease2-year follow-upn = 40
Safety and efficiency of deep brain stimulation in the elderly patients with Parkinson's disease
CNS neuroscience & therapeutics
Latest
8 papers in 12 monthsNeurorehabilitation and Neural Repair
Efficacy of Aerobic Exercise on Brain MRI Measures in Parkinson's Disease
Randomized trial in 70 peopleAerobic exercise
Neurological Sciences
Efficacy and safety of GLP-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized clinical trials
Meta-analysis of randomized trialsGLP-1 receptor agonists
CNS Neuroscience & Therapeutics
Safety and efficiency of deep brain stimulation in the elderly patients with Parkinson's disease
Cohort study of 40 peopleParkinson's disease
Technology and Health Care
Sensor-integrated AI-assisted gait training in dementia and Parkinson's disease: A single-session pre-post study
Non-randomized trial in 67 peopleParkinson's disease
Parkinsonism & Related Disorders
Association of early adjunctive dopaminergic therapy and 5-year mortality in Parkinson's disease: A nationwide cohort study
Cohort study of 4,949 peopleParkinson's disease
Neurological Research and Practice
Wearable sensor measurements in relation to clinical characteristics and mortality in patients with Parkinson's disease
Cohort study of 286 peopleParkinson's disease
GeroScience
Relationship between frailty and disease progression in Parkinson's disease: a 3-year longitudinal study
Cohort study of 109 peopleParkinson's disease
Parkinsonism & Related Disorders
Long-term outcomes associated with istradefylline versus catechol-O-methyltransferase inhibitors in patients with Parkinson's disease: a nationwide real-world cohort study
Cohort study of 7,986 peopleParkinson's disease
Frontiers in Aging Neuroscience
Clinical analysis of sarcopenia prevalence and its influencing factors in patients with Parkinson's disease
Cross-sectional study of 97 peopleParkinson's disease